薬学および生命科学における研究開発の国際ジャーナル

抽象的な

REVIEW ON PHARMACOLOGICAL ACTIVITIES OF LIGUSTRUM OVALIFOLIUM

Harsha Matoli, Ashish Mangal, Pranav Vashistha, Megha Jain, love S. Chokotia

The identification of privet in the middle southern United States can be difficult. Because most introduced species of privet can be invasive, and recent mapping projects seek location and species population data, proper identification is important. Ligustrum is currently marketed as a treatment for strengthening the immune system, R 3\05\ 9and on this basis is often recommended for use by people undergoing treatment for cancer or HIV. There is no meaningful scientific evidence that ligustrum provides any benefit for these, or any other, conditions. Very weak evidence from test-tube and animal studies hints that ligustrum might have anti-parasitic, 1 anti-viral, 2l iver-protective , 3immunomodulatory (this means “altering” immune function, rather than, as commonly misunderstood, “strengthening” it), 4,5 and cancer-preventive 6 effects. However, this evidence is too preliminary to rely upon at all. Ligustrum ovalifolium are used the activities of hypotensive activity, hypoglycemic activity, anti inflammatory activity and antioxidant activity.